000013713 001__ 13713
000013713 005__ 20230228114625.0
000013713 0247_ $$2CORDIS$$aG:(EU-Grant)230629$$d230629
000013713 0247_ $$2CORDIS$$aG:(EU-Call)FP7-SME-2008-1$$dFP7-SME-2008-1
000013713 0247_ $$2originalID$$acorda_______::230629
000013713 035__ $$aG:(EU-Grant)230629
000013713 150__ $$aDevelopment of carbon monoxide releasing molecules for the treatment of rheumatoid arthritis$$y2009-11-01 - 2011-10-31
000013713 371__ $$aSwiss BioQuant AG$$bSwiss BioQuant$$dSwitzerland$$ehttp://www.swissbioquant.com$$vCORDIS
000013713 371__ $$aAlfama - Investigacao e Desenvolvimento de Produtos Farmaceuticos, Lda.$$bAlfama$$dPortugal$$ehttp://www.alfama.com.pt$$vCORDIS
000013713 371__ $$aMicron Research Service$$bMicron$$dItaly$$ehttp://www.micronrs.com$$vCORDIS
000013713 371__ $$aFrimorfo SA$$bFrimorfo$$dSwitzerland$$ehttp://www.frimorfo.com$$vCORDIS
000013713 371__ $$aINSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES$$biMM$$dPortugal$$ehttps://imm.medicina.ulisboa.pt/en/$$vCORDIS
000013713 371__ $$aALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU$$bALTA SRLU$$dItaly$$ehttp://www.altaweb.eu$$vCORDIS
000013713 371__ $$aUniversity of Catania$$bUniversity of Catania$$dItaly$$ehttp://www.unict.it/$$vCORDIS
000013713 372__ $$aFP7-SME-2008-1$$s2009-11-01$$t2011-10-31
000013713 450__ $$aCORMRA$$wd$$y2009-11-01 - 2011-10-31
000013713 5101_ $$0I:(DE-588b)5098525-5$$2CORDIS$$aEuropean Union
000013713 909CO $$ooai:juser.fz-juelich.de:121851$$pauthority$$pauthority:GRANT
000013713 909CO $$ooai:juser.fz-juelich.de:121851
000013713 970__ $$aoai:dnet:corda_______::4a0b3236fad207c894f096c574884b04
000013713 980__ $$aG
000013713 980__ $$aCORDIS
000013713 980__ $$aAUTHORITY